Cover Image
市場調查報告書

黑色素瘤:全球臨床實驗趨勢

Melanoma Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 217232
出版日期 內容資訊 英文 1403 Pages
訂單完成後即時交付
價格
Back to Top
黑色素瘤:全球臨床實驗趨勢 Melanoma Global Clinical Trials Review, H1, 2016
出版日期: 2016年01月31日 內容資訊: 英文 1403 Pages
簡介

本報告提供黑色素瘤治療藥的臨床實驗資料,彙整各國的趨勢,臨床試驗數,全球各臨床實驗中心的募集情況等結果。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:黑色素瘤臨床實驗數量佔腫瘤臨床實驗數量比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:黑色素瘤臨床實驗數量佔腫瘤臨床實驗數量比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 黑色素瘤 治療藥

有潛力的藥劑

  • 最新臨床實驗新聞:黑色素瘤

臨床實驗簡介的基本資料

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3214CTIDB

GlobalData's clinical trial report, "Melanoma Global Clinical Trials Review, H1, 2016" provides an overview of Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Melanoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Melanoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Melanoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Melanoma Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Melanoma
      • Jan 21, 2016: Philogen Announces Commencement of Phase III Pivotal Trial in Melanoma
      • Jan 12, 2016: Provectus Biopharmaceuticals Confirms First Patients Dosed in Phase 3 Trial of PV-10 for Melanoma
      • Jan 06, 2016: Navidea Biopharmaceuticals Enrolls First Patient in Pediatric Trial of Lymphoseek
      • Dec 16, 2015: Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma
      • Dec 03, 2015: Lymphoseek Reduces Sentinel Lymph Node Biopsy Imaging Time, Facilitating Patient Throughput and Workflow Efficiencies
      • Nov 09, 2015: New Preclinical Data Presented At SITC Annual Meeting Highlight Bavituximab's Enhanced Anti-Tumor Activity When Combined With Checkpoint Inhibitors In Breast Cancer And Melanoma
      • Nov 06, 2015: Kolltan Pharmaceuticals Presents KTN3379 Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Melanoma Therapeutics, Global, Clinical Trials by Region, 2016*
  • Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Melanoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
  • Proportion of Melanoma to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Melanoma to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Melanoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Melanoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Melanoma Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Melanoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
  • Proportion of Melanoma to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Melanoma to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Melanoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Melanoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top